An observational study in Transthyretin Amyloidosis and Carpal Tunnel Syndrome, sponsored by Universidade do Porto. Recruiting at 2 sites in Portugal. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-10-19.
Sponsored by Universidade do Porto · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Amyloidosis, Hereditary, Transthyretin-Related with a site in Portugal — 7 open to participants now, 9 under way, 4 of them phase 3. Amyloidosis, Hereditary, Transthyretin-Related · Portugal.
Among the 15 studies in Amyloidosis, Hereditary, Transthyretin-Related with a site in Portugal, this one is one of 2 that started in 2020, is one of 5 observational ones, and was the 10th registered.
82 studies on the registry are indexed under Amyloidosis, Hereditary, Transthyretin-Related; 28 are open to participants now.
Browse Amyloidosis, Hereditary, Transthyretin-Related studies →7 of the 15 studies in Amyloidosis, Hereditary, Transthyretin-Related with a site in Portugal are open now. Recruiting first, the newest first:
Bayer · Sites in Portugal, Austria, Belgium and 14 more countries
Ages 18+
Eidos Therapeutics, a BridgeBio company · Sites in Portugal, United States, Argentina and 21 more countries
Ages 18–75
University of Maia · Sites in Portugal
Ages 18+
Intellia Therapeutics · Sites in Portugal, United States, Argentina and 23 more countries
Ages 18–90
Alnylam Pharmaceuticals · Sites in Portugal, United States, Brazil and 9 more countries
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 22 Amyloidosis, Hereditary, Transthyretin-Related studies recruiting now, 15 (68%) set no upper age limit and 1 (5%) stops at 75 or younger; 2 take children under 18; 4 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2020.
This study's planned enrollment of 100 is close to the median of 100 across 40 observational studies indexed under Amyloidosis, Hereditary, Transthyretin-Related.
Median enrollment 474 across the 10 interventional studies, 1,500 across the 5 observational. Of the 6 that completed or were terminated, 6 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 15 have an industry lead sponsor. The 8 most frequent:
Universidade do Porto is the lead sponsor of 174 studies on the registry; 53 are open to participants now.
Universidade do Porto has 1 study filed under Amyloidosis, Hereditary, Transthyretin-Related — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Amyloidosis, Hereditary, Transthyretin-Related with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Systemic transthyretin amyloidosis is an aging-related disorder. It is usually associated with cardiac disease but also extends to other organs. Recent studies found that idiopathic carpal tunnel syndrome patients may have amyloid deposition in tenosynovial tissue. The main aims of this project are the characterization of the association between idiopathic carpal tunnel syndrome and transthyretin amyloidosis and its evaluation as a predictive factor of cardiac amyloidosis
Patients with ≥60 years old submitted to hand surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
. Patients aged ≥ 60 years old with symptomatic idiopathic carpal tunnel syndrome or other hand surgery indications.
Exclusion Criteria:
. Diabetes mellitus, hypothyroidism, hemodialysis, rheumatoid arthritis, and other inflammatory arthropathies, multiple myeloma, gout, chondrocalcinosis, Colles fracture, space-occupying lesions, and infectious synovitis.
Patients aged ≥ 60 years old with symptomatic carpal tunnel syndrome submitted to surgery
Diagnostic Test: Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
Patients aged ≥ 60 years old without symptomatic carpal tunnel syndrome submitted to hand surgery
Diagnostic Test: Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis
Frequency of transthyretin amyloidosis in synovial in patients with ≥60 years old
Number of patients with transthyretin amyloidosis in synovial in relation to total number of patients submitted to hand surgery
Time frame: 24 months
Association between synovial transthyretin amyloidosis with carpal tunnel syndrome
Comparison between group 1 and 2
Time frame: 24 months
Association between idiopathic carpal tunnel syndrome with cardiac transthyretin amyloidosis
Comparison between group 1 and 2
Time frame: 24 months
Started Jun 2020 (actual). Primary completion is estimated for Jun 2024, 48 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Amyloidosis, Hereditary, Transthyretin-Related →